| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |